A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
Public ClinicalTrials.gov record NCT00658567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety and efficacy of two dose levels of pimavanserin (ACP-103) compared to placebo in patients with Parkinson's disease psychosis.
Study identification
- NCT ID
- NCT00658567
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 123 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2008 (Type not available)
- Primary completion
- Dec 2009 (Actual)
- Completion
- Dec 2009 (Actual)
- Last update posted
- May 19, 2017
2008 – 2009
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | La Habra | California | 90631 | — |
| Not listed | Laguna Hills | California | 92653 | — |
| Not listed | Reseda | California | — | — |
| Not listed | Ventura | California | 93003 | — |
| Not listed | Englewood | Colorado | 80113 | — |
| Not listed | Farmington | Connecticut | 06030 | — |
| Not listed | Deerfield Beach | Florida | 33064 | — |
| Not listed | Panama City | Florida | 32405 | — |
| Not listed | Sarasota | Florida | 34233 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Worcester | Massachusetts | 01655 | — |
| Not listed | Clinton | Michigan | 48035 | — |
| Not listed | Detroit | Michigan | 48201 | — |
| Not listed | East Lansing | Michigan | 48824 | — |
| Not listed | Columbia | Missouri | 65201 | — |
| Not listed | Omaha | Nebraska | 68131 | — |
| Not listed | Albany | New York | 12208 | — |
| Not listed | Commack | New York | 11725 | — |
| Not listed | Charlotte | North Carolina | 28204 | — |
| Not listed | Durham | North Carolina | 27705 | — |
| Not listed | New Bern | North Carolina | — | — |
| Not listed | Toledo | Ohio | 43614 | — |
| Not listed | Philadelphia | Pennsylvania | 19131 | — |
| Not listed | Philadelphia | Pennsylvania | 19141 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Burlington | Vermont | 05401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00658567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2017 · Synced Nov 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00658567 live on ClinicalTrials.gov.